1.78
Health Catalyst Inc stock is traded at $1.78, with a volume of 1.02M.
It is down -3.26% in the last 24 hours and up +49.58% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$1.84
Open:
$1.84
24h Volume:
1.02M
Relative Volume:
0.81
Market Cap:
$131.53M
Revenue:
$302.48M
Net Income/Loss:
$-265.26M
P/E Ratio:
-0.479
EPS:
-3.716
Net Cash Flow:
$-2.76M
1W Performance:
+4.09%
1M Performance:
+49.58%
6M Performance:
-27.05%
1Y Performance:
-54.12%
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HCAT
Health Catalyst Inc
|
1.78 | 135.96M | 302.48M | -265.26M | -2.76M | -3.716 |
|
VEEV
Veeva Systems Inc
|
163.38 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
64.14 | 12.58B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
50.56 | 9.39B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
85.66 | 7.27B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
HNGE
Hinge Health Inc
|
67.81 | 5.29B | 646.34M | -512.40M | 202.76M | -6.6871 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Health Catalyst (HCAT) CEO uses 34,485 shares to cover RSU tax bill - Stock Titan
Health Catalyst jumps on announcement to sell Vitalware to Med‑Metrix for $147M - MSN
HCAT News | HEALTH CATALYST INC (NASDAQ:HCAT) - ChartMill
Health Catalyst (HCAT) Form 144: 34,485 restricted shares planned sale 06/10/2026 - Stock Titan
Health Catalyst, Tenable, and Pegasystems Stocks Trade Down, What You Need To Know - Yahoo Finance
Health Catalyst to Cut 9% of Workforce - Moomoo
Whetstone updates Health Catalyst (HCAT) ownership to 4.5% stake - Stock Titan
Health Catalyst, Inc. - MLQ.ai
HCAT's Vitalware sale brings relief, and a reckoning - Axios
Health Catalyst Inc (HCAT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Health Catalyst Company Profile & Introduction - Moomoo
Veru And 2 Other Intriguing Penny Stocks To Watch - simplywall.st
Med-Metrix to acquire Vitalware to strengthen net revenue yield - ROI-NJ
3 Russell 2000 Stocks That Fall Short - The Globe and Mail
Health Catalyst to Divest Vitalware Unit for $147M to Med-Metrix - HIT Consultant
Latham & Watkins Advises Health Catalyst on Divestiture of Vitalware - Latham & Watkins LLP
Health Catalyst to Sell Vitalware for $147 Million; Shares Rise Pre-Bell - Moomoo
Health Catalyst to sell Vitalware unit for $147 million cash By Investing.com - Investing.com Nigeria
Med-Metrix, LLC entered into a definitive agreement to acquire Vitalware, LLC from Health Catalyst, Inc.. - marketscreener.com
Health Catalyst (HCAT) Divests Vitalware for $147 Million - GuruFocus
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Didn't see the 300%—it's pretty obvious when you keep losing money 🥲 - Moomoo
Med-Metrix to acquire Vitalware from Health Catalyst By Investing.com - Investing.com Australia
Med-Metrix to acquire Vitalware from Health Catalyst - Investing.com UK
Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield - PR Newswire
HCAT Stock Jumps As Strategic Reset Follows Earnings Beat - StocksToTrade
Health Catalyst to sell Vitalware unit for $147 million cash - Investing.com
Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation - The Manila Times
Health Catalyst to Sell Vitalware Business to Med-Metrix for $147 Million, Repay Term Loan - TradingView
Health Catalyst Announces Divestiture of Vitalware to Med-Metrix for $147 Million - Quiver Quantitative
Health Catalyst (NASDAQ: HCAT) divests Vitalware to repay term loan debt - Stock Titan
Selling a side business, Health Catalyst plans to pay off $160M loan - Stock Titan
Small tax-withholding sale by Health Catalyst (HCAT) CEO disclosed - Stock Titan
Health Catalyst (HCAT) CPO uses 8,519 shares in mandated tax sell-to-cover - Stock Titan
Health Catalyst (HCAT) CFO mandated share sale to cover RSU taxes - Stock Titan
Health Catalyst (HCAT) General Counsel sells shares to cover RSU tax withholding - Stock Titan
Health Catalyst (HCAT) director awarded 12,710 RSUs, now holds 94,644 shares - Stock Titan
Health Catalyst (HCAT) investors to vote on declassifying board and pay - Stock Titan
Health Catalyst Inc stock (US42226A1079): Insider share sale surfaces as earnings backdrop stays in - AD HOC NEWS
Benjamin Albert files to sell 336 HCAT shares (HCAT) - Stock Titan
Health Catalyst (HCAT) affiliate files to sell 18,804 restricted shares on 06/01/2026 - Stock Titan
Linda Llewelyn files to sell 8,519 restricted shares (HCAT) - Stock Titan
Health Catalyst (HCAT) Rule 144: insider sale of 13,779 restricted shares - Stock Titan
What's Driving the Recent Buzz Around Health Catalyst (HCAT) and ZoomInfo (ZI) Stocks - Kavout
Health Catalyst Inc stock (US42226A1079): shares edge higher as Nasdaq health-data name digests late - AD HOC NEWS
Health Catalyst | 4: Statement of changes in beneficial ownership of securities-Director Nelson Steven H - Moomoo
Health Catalyst Inc (HCAT) Share Price Today | Health Catalyst (HCAT) Live NSE/BSE - Value Research
Health Catalyst Q1 2026 Results: Revenue Decline, Client Migration Issues, and Strategic ShiftsNews and Statistics - IndexBox
EDGAR Filing Documents for 0001636422-25-000010 - SEC.gov
MongoDB, Health Catalyst, and Qualys Shares Are Soaring, What You Need To Know - Yahoo Finance
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):